This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ruggeri L, Mancusi A, Capanni M, Burchielli E, Perruchio K, Aversa F et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood 2007; 110: 433–440.
de Pagter P, Schuurman R, Meijer E, van Baarle D, Sanders E, Boelens J . Human herpesvirus type 6 reactivation after haematolpoietic stem cell transplantation. J Clin Virol 2008; 43: 361–366.
Cone R, Huand M, Corey L, Zeh J, Ashley R, Bowden R . Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. J Inf Dis 1999; 179: 311–318.
Zerr D, Corey L, Kim H, Huang M, Nguy L, Boeckh M . Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Inf Dis 2005; 40: 932–940.
Dodero A, Carniti C, Raganato A, Vendramin A, Farina L, Spina F et al. Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery. Blood 2009; 113: 4771–4779.
Wang F, Linde A, Dahl H, Ljungmann P . Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplant 1999; 24: 1201–1206.
Wand L, Dong L, Zhang M, Lu D . Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 42: 673–677.
Kitamura K, Asada H, Iida H, Fukumoto T, Kobayashi N, Niizeki H et al. Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation. J Am Acad Dermatol 2008; 58: 802–809.
Wilborn F, Brinkmann V, Schmidt C, Neipel F, Gelderblom H, Siegert W . Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 1994; 83: 3052–3058.
Ljungmann P, Singh N . Human herpesvirus-6 infection in solid organ and stem cell transplant recipients. J Clin Virol 2006; 37 (Suppl1): 87–91.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Brands-Nijenhuis, A., van Loo, I., Schouten, H. et al. Temporal relationship between HHV 6 and graft vs host disease in a patient after haplo-identical SCT and severe T-cell depletion. Bone Marrow Transplant 46, 1151–1152 (2011). https://doi.org/10.1038/bmt.2010.245
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.245
This article is cited by
-
HHV-6B infection, T-cell reconstitution, and graft-vs-host disease after hematopoietic stem cell transplantation
Bone Marrow Transplantation (2018)
-
DRESS or ‘picture of DRESS’
Bone Marrow Transplantation (2012)